Scientists capture first images of an autoantibody attacking a neuron receptor
Posted: 15 July 2022 | Ria Kakkad (Drug Target Review) | No comments yet
Researchers for the first time have captured images of an autoantibody bound to a nerve cell surface receptor, revealing the physical mechanism behind a neurological autoimmune disease.


Scientists from the German Center for Neurodegenerative Diseases (DZNE), and the University of Texas Southwestern Medical Center, US, have for the first time captured images of an autoantibody bound to a nerve cell surface receptor, revealing the physical mechanism behind a neurological autoimmune disease. The findings, which were published in Cell, could lead to new ways to diagnose, and treat autoimmune conditions.
Researchers in Germany recently identified a patient, then 8 years old, whose autoimmune encephalitis appeared to be caused by antibodies that attack the GABAA receptor, a protein that sits on the surface of synapses – specialised structures that connect brain cells. This receptor’s role is to inhibit neuronal firing, balancing the electrical signals prompted by excitatory receptors to maintain healthy signalling between nerve cells.
After confirming that two kinds of antibodies derived from this young patient’s immune cells readily bound to the GABAA receptor, the researchers performed cryo-electron microscopy (cryo-EM) for each antibody bound to the receptor.
Biomarkers aren’t just supporting drug discovery – they’re driving it
FREE market report
From smarter trials to faster insights, this report unpacks the science, strategy and real-world impact behind the next generation of precision therapies.
What you’ll unlock:
- How biomarkers are guiding dose selection and early efficacy decisions in complex trials
- Why multi-omics, liquid biopsy and digital tools are redefining the discovery process
- What makes lab data regulatory-ready and why alignment matters from day one
Explore how biomarkers are shaping early drug development
Access the full report – it’s free!
“For the first time, we have exploited the interface between two fields that have developed strongly in recent times: on the one hand, cryo-electron microscopy, which manages to image individual atoms, and on the other hand, research on clinically relevant autoantibodies, that we isolate from patients with neurological and psychiatric diseases. The expertise from both fields has merged here,” said Professor Harald Prüß, a DZNE scientist
The images show that, both together and separately, the antibodies prevent the GABAA receptor from inhibiting neuronal signalling, causing neurons to become too electrically excited and leading to brain inflammation, cell death, and seizures characteristic of autoimmune encephalitis. The researchers claim that screening for these antibodies could lead to better diagnosis of this condition, likewise, finding ways to block the interaction between these antibodies and their target could lead to better ways to treat it.
The scientists plan to make the study of these disorders using cryo-EM a focus of their research.
Related topics
Antibodies, Antibody Discovery, Microscopy, Neurons
Related conditions
autoimmune disease
Related organisations
German Center for Neurodegenerative Diseases (DZNE), University of Texas Southwestern Medical Center
Related people
Professor Harald Prüß